ProKidney Corp Sustainability Reports
ProKidney Corp. is a clinical-stage biotechnology company developing proprietary autologous cell therapies designed to preserve, restore, or improve kidney function in patients with advanced chronic kidney disease.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
3 reports from 2022 to 2024
Company Profile
ProKidney Corp. is a clinical-stage biotechnology company developing proprietary autologous cell therapies designed to preserve, restore, or improve kidney function in patients with advanced chronic kidney disease.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
